Literature DB >> 8747133

Inefficacy of pefloxacin in steroid-responsive nephrotic syndrome.

A Bagga, A Sharma, R N Srivastava.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8747133     DOI： 10.1007/bf00868751

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  6 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  Pefloxacin as first-line treatment in nephrotic syndrome.

Authors:  A Pruna; F Metivier; K Akposso; C Saltiel; J Bedrossian; J M Idatte; D Nochy; P Druet
Journal:  Lancet       Date:  1992-09-19       Impact factor: 79.321

3.  Side-effects of pefloxacin in idiopathic nephrotic syndrome.

Authors:  E J Aigrain; P Brun; S Bennasr; C Loirat
Journal:  Lancet       Date:  1993-08-14       Impact factor: 79.321

4.  Inefficacy and toxicity of pefloxacin in focal and segmental glomerulosclerosis with steroid-resistant nephrotic syndrome.

Authors:  C Geffriaud-Ricouard; P Jungers; D Chauveau; J P Grünfeld
Journal:  Lancet       Date:  1993-06-05       Impact factor: 79.321

5.  Pefloxacin as first-line treatment in nephrotic syndrome.

Authors:  C Ginsburg; D Toledano; G Deray; D Vlassopoulos; A Baumelou; C Jacobs
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

6.  Fluorinated 4-quinolones induce hyperproduction of interleukin 2.

Authors:  K Riesbeck; J Andersson; M Gullberg; A Forsgren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205
  6 in total
  1 in total

Review 1.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.